US Pharma MarketingThe post FDA clears SurGenTec’s facet fixation system for degenerative disc disease treatment appeared first on Medical Device Network.
FDA clears SurGenTec’s facet fixation system for degenerative disc disease treatment
Cleared by the FDA based on data from an IRB-approved study, SurGenTec’s ION-L facet provides a less invasive approach to spinal fixation. Cleared on the basis of data from an IRB-approved study, SurGenTec’s ION-L facet is designed to provide a less invasive approach to spinal fixation. Degenerative disc disease is common, with around 40% experienced at least one degenerated disc by age 40. Credit: Tada Images / Shutterstock.com SurGenTec has secured US Food and Drug Administration (FDA) clearance for ION-L, a lumbar facet fixation system for treating degenerative disc disease (DDD) patients who have not benefited from conservative care protocols.…
Cleared by the FDA based on data from an IRB-approved study, SurGenTec’s ION-L facet provides a less invasive approach to spinal fixation.
Source: Medical Device Network